Jefferies Group’s Achillion Pharmaceuticals ACHN Stock Holding History

Jefferies Group’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-577,179	Closed	-$3.48M	–	2945
2019 Q4	$3.48M	Buy	+577,179	New	+$3.34M	0.03%	718
2019 Q3	–	Sell	-18,373	Closed	-$49K	–	3212
2019 Q2	$49K	Buy	18,373 +1,282	+8%	+$3.79K	﹤0.01%	2367
2019 Q1	$51K	Sell	17,091 -100,437	-85%	-$247K	﹤0.01%	2199
2018 Q4	$187K	Buy	117,528 +37,322	+47%	+$106K	﹤0.01%	1851
2018 Q3	$295K	Sell	80,206 -11,305	-12%	-$33.7K	﹤0.01%	1887
2018 Q2	$259K	Buy	91,511 +77,511	+554%	+$264K	﹤0.01%	1918
2018 Q1	$52K	Buy	+14,000	New	+$45.8K	﹤0.01%	2121
2015 Q2	–	Sell	-10,600	Closed	-$100K	–	3593
2015 Q1	$105K	Sell	10,600 -4,400	-29%	-$54.9K	﹤0.01%	1863
2014 Q4	$184K	Sell	15,000 -87,673	-85%	-$1.07M	﹤0.01%	1763
2014 Q3	$1.02M	Sell	102,673 -24,037	-19%	-$223K	0.01%	1002
2014 Q2	$959K	Buy	126,710 +63,010	+99%	+$251K	0.01%	925
2014 Q1	$210K	Buy	+63,700	New	+$223K	﹤0.01%	1713

Jefferies Group's ACHN Position: Q1 2020 in Review

Jefferies Group sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 577,179 shares — an estimated $3.48M sold.

Jefferies Group first reported a position in ACHN in Q1 2014 and held it in 12 quarters. The position peaked at $3.48M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Jefferies Group reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 577,179 Achillion Pharmaceuticals shares in Q1 2020, an estimated $3.48M.
Jefferies Group first reported a position in Achillion Pharmaceuticals in Q1 2014 and held it in 12 quarters.
Jefferies Group's Achillion Pharmaceuticals position peaked at $3.48M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.